NORepinephrine 4 mg/250 mL added to 0.9% sodium recall: Sterility Concern
NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd…
Why was NORepinephrine 4 mg/250 mL added to 0.9% sodium recalled?
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 36-241043, 36-241044, 36-241045, 36-241046, Exp. 7/18/2023.
- Product
- NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd…
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Quantity
- I,I87 bags.
- Distribution
- Nationwide in the USA
- Recall date
- August 9, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)